Silberstein, S., Dodick, D., DeGryse, R., Lipton, R., & Turkel, C. (2013). The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program. Springer.
Citação norma ChicagoSilberstein, S., DW Dodick, RE DeGryse, R. Lipton, and CC Turkel. The Percent of Chronic Migraine Patients Who Responded to OnabotulinumtoxinA Treatment Per Treatment Cycle in the PREEMPT Clinical Program. Springer, 2013.
Citação norma MLASilberstein, S., et al. The Percent of Chronic Migraine Patients Who Responded to OnabotulinumtoxinA Treatment Per Treatment Cycle in the PREEMPT Clinical Program. Springer, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.